Reasons given by patients for participating, or not, in Phase 1 cancer trials.
about
Adolescent perspectives on phase I cancer researchTraditional roles in a non-traditional setting: genetic counseling in precision oncologyPromoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives.Evaluation of patient enrollment in oncology phase I clinical trials.Informed consent for HIV cure research in South Africa: issues to consider.Research biopsies in the context of early phase oncology studies: clinical and ethical considerations.Factors influencing participation in a randomized controlled resistance exercise intervention study in breast cancer patients during radiotherapy.Culturally Competent Strategies for Recruitment and Retention of African American Populations into Clinical TrialsGene therapy researchers' assessments of risks and perceptions of risk acceptability in clinical trials.Drivers and barriers to patient participation in RCTs.The effects of cancer research participation on patient experience: a mixed-methods analysis.Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.Personalized oncology: genomic screening in phase 1.Reasons behind the participation in biomedical research: a brief review.Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.A Qualitative Study of Decision-Making on Phase III Randomized Clinical Trial Participation in Pediatric Oncology: Adolescents' and Parents' Perspectives and Preferences.Understanding how coping strategies and quality of life maintain hope in patients deliberating phase I trial participation.Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients.The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory study.Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.How did partners experience cancer patients' participation in a phase I study? An observational study after a patient's death.Engaging patients and caregivers in patient-centered outcomes research on advanced stage lung cancer: insights from patients, caregivers, and providers.Patient information in phase 1 trials: A systematic review.
P2860
Q30531481-9C217CF7-8300-4B49-AA4F-6E6718FA08F7Q33894053-2CAD53B1-C0E9-4C99-9A53-89E4597AB5D5Q33956979-E4FB4445-2BC7-4F0B-BA26-87A762A3FFE5Q34594562-A0E21B35-ED4C-4571-B3F4-22BD1BC0AA98Q35071520-E562E97E-AF37-4501-9C70-08BFA49BECBEQ35569312-B7124458-6655-4838-A559-F1CF57E328D2Q35606109-F9F778D3-3D7B-44BC-961A-202BE77689CFQ36225685-86EE5227-62FE-4498-B45A-1D6E9521577CQ36740288-CB2FFD24-5F8E-477C-866B-C55AE3C1C84BQ36775343-21F26C3A-0847-4F14-995D-2091333C76ABQ37394054-0BA59892-06FB-479B-B00A-F4E4785327CEQ37404400-1628A41E-1D87-45AA-AC82-578B85B6C27CQ38232150-3F6AB8B1-A38D-49E2-A9D9-DBD93F74B24AQ38267290-A431927E-42D1-413B-891B-04BBD01DFF65Q38319483-1188FE7D-60E0-4BB9-95DA-468C9B20C148Q38387634-76EB01D9-3913-408A-8DED-91BED29F8540Q38644166-4127D88A-C370-4C02-836D-6201CEC1D1FCQ38700608-B068FB3A-ABC1-4BE9-B9E3-0669D624C644Q46306875-926FCFD9-C026-4EFF-8198-FD96DEEB4343Q46587807-58B37695-0C34-45D6-ACC9-A359B97E5F78Q47307730-CC6E7C08-4F14-4771-BA1E-70D79E6AFB14Q47608073-0E7BC259-71FB-44FB-9FDA-45D2B04CE80DQ48079420-AE25E774-A7CF-4397-8F05-204F31263ACDQ48270408-DC2E3384-4716-474C-BDA5-514324C1B429
P2860
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@en
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@nl
type
label
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@en
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@nl
prefLabel
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@en
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@nl
P2093
P1476
Reasons given by patients for participating, or not, in Phase 1 cancer trials.
@en
P2093
P304
P356
10.1016/J.EJCA.2011.02.020
P577
2011-03-30T00:00:00Z